Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Bullboard Posts
Post by wtelfairon Dec 27, 2010 11:30am
325 Views
Post# 17896915

Trying Again- Dale Paruk email

Trying Again- Dale Paruk email

Thank you for visiting the NioGold website. We have added your email address to our list for news.





NioGold Mining (TSX-V: NOX) is a gold company focused in Quebec with several key properties. Our Malartic project is located 5 hours north of Montreal between the towns of Malartic and Val d’Or in the second largest gold region in North America. Over 45,000,000 oz gold have been produced in our 3 gold camps with over 15,000,000 oz gold in reserve. We are adjoining Osisko Mines and their developing 9,000,000 oz deposit that is scheduled for production in 2011.

NioGold has recently delivered a 43-101 report with 600,000 oz gold indicated and 360,000 oz gold inferred. The deposit has significant upside and only 20% of the targeted trend has been drilled. Exploration is continuing.

NioGold has entered into an agreement with Aurizon Mines wherein Aurizon is funding $20,000,000 of development drilling at Marban after which it will make a resource payment to NioGold for ½ the deposit estimated at $30,000,000. NioGold is the operator of the 3 year program. NioGold remains 100% in control of the balance of our properties, approximately 90% of 120 sq.km.

We have added your email to our list for news. Thank you for your interest.

Here is a link to our PowerPoint Presentation:

https://niogold.com/wp-content/uploads/2010/09/NOX_Presentation_2010-09.pdf

Bullboard Posts